Bioprinting is in the vanguard of the war against the novel coronavirus and holds promise for greater understanding of the way SAR-CoV-2 works in the human body. Ultimately, it may aid work in the prevention and treatment of COVID-19, the illness caused by the virus, and demonstrate bioprinting’s potential to reduce animal testing and speed research.